PATENT CLAIM ANALYSIS

Application Number: 16009132
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["435", "188000"]

Abstract:
The present invention is directed to compositions comprising a polymer backbone with protective chain and anionic groups, and a cationic therapeutic agent. The present invention is directed to compositions for treating infections, inflammatory diseases, excess growth, and damaged cells and organs.

Claim (Index 80):
The composition of  claim 76 , wherein the load molecule comprises an agent selected from the group consisting of SEQ ID NOS: 1-59, lysostaphin, an epithelial growth factor (EGF), an interferon, a Fibroblast growth factor (FGF), a Vascular endothelial growth factor (VEGF), Hepatocyte growth factor (HGF), a Transforming growth factor (TGF), Nerve growth factor (NGF), and a Platelet derived growth factor (PDGF).

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.46875
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13395090', '14628118', '12711564', '15672802', '14087523']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6541435065719774
- 35 USC 102 Novelty (BERT): 0.5729619177647919
- Combined Prediction Score: 0.6460253476912589
- Mean Citation Score: 293.448004
- Max Citation Score: 482.88193
- Similarity Product: 409.9616818846703

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test